Edesa Biotech, Inc

(NASDAQ:EDSA)

Latest On Edesa Biotech, Inc (EDSA):

Date/Time Type Description Signal Details
2023-05-11 19:16 ESTNewsEdesa Biotech GAAP EPS of -$0.12 beats by $0.05N/A
2023-02-10 13:00 ESTNewsEdesa Biotech GAAP EPS of -$0.13 beats by $0.06N/A
2023-02-01 16:16 ESTNewsEdesa gets Health Canada nod to start mid-stage study for vitiligo drugN/A
2023-01-17 19:41 ESTNewsEdesa stock slumps 30% amid skin rash drug's mixed phase 2b trial resultsN/A
2022-12-22 14:23 ESTNewsRENN, LX and THMO among premarket gainersN/A
2022-12-20 11:10 ESTNewsFDA grants fast track nod to Edesa's COVID antibody for respiratory distressN/A
2022-12-16 21:08 ESTNewsEdesa Biotech GAAP EPS of -$1.05 beats by $0.39N/A
2022-09-30 16:39 ESTNewsEdesa shares jump ~11%, says monoclonal antibody cuts risk of death due to COVID by 84%N/A
2022-09-07 17:34 ESTNewsEdesa says mid-stage trial for anti-allergic cream reached full enrollmentN/A
2022-08-12 18:29 ESTNewsEdesa Biotech GAAP EPS of -$0.37 beats by $0.06N/A
2022-05-13 12:12 ESTNewsEdesa Biotech GAAP EPS of -$0.33N/A
2022-04-18 14:43 ESTNewsEdesa Biotech: Leader In Developing Treatments For COVID-19 And ACDN/A
2022-03-23 00:31 ESTNewsEdesa Biotech slips on ~$10M share offeringN/A
2022-01-13 14:36 ESTNewsEdesa Biotech secures Canadian approval to test COVID-19 drug as rescue therapyN/A
2021-12-29 18:55 ESTNewsEdesa Biotech EPS beats by $0.10N/A
2021-10-19 09:29 ESTNewsEdesa Biotech monoclonal antibody cuts risk of death due to COVID-19 by 69%N/A
2021-09-23 02:01 ESTNewsEdesa Biotech Reports Positive Phase 2 Data In Critically-Ill COVID PatientsN/A
2021-09-21 17:13 ESTNewsEdesa surges 60% on positive phase 2 results of COVID antibody candidate EB05N/A
2021-09-21 17:11 ESTNewsEdesa down 20%, paring huge gains made yesterday from COVID antibody dataN/A
2021-08-13 12:42 ESTNewsEdesa Biotech EPS misses by $0.04N/A
2021-07-21 06:53 ESTNewsEdesa Biotech posts positive interim results in EB01 Dermatitis trialN/A
2021-07-21 06:41 ESTNewsEdesa Biotech soars 10% on DSMB recommendation to continue COVID-19 studyN/A
2021-07-21 06:14 ESTNewsEdesa Biotech extends EB01 mid-stage dermatitis study to CanadaN/A
2021-03-23 02:17 ESTNewsEdesa Biotech stock surges after expanding rights to anti-inflammatory technologyN/A
2021-03-16 23:35 ESTNewsEdesa Biotech shares rise after reaching enrollment milestone in COVID-19 studyN/A
2021-03-09 16:07 ESTNewsEdesa Biotech completes enrollment in mid-stage Dermatitis study cohort 1N/A
2021-02-26 00:05 ESTNewsEdesa Bio secures $10M capital raiseN/A
2021-02-18 03:42 ESTAnalyst RatingThe Analyst Target Price has increased from $16.5 to $17.Buy
2021-02-17 23:33 ESTFinancialsCompany financials have been released.Neutral
2021-02-17 20:28 ESTNewsEdesa Biotech EPS beats by $0.02N/A
2021-02-17 11:26 ESTAnalyst RatingThe Analyst Target Price has increased from $15.5 to $16.5.Buy
2021-02-17 11:26 ESTEarnings EstimateAn EPS average of -$0.16 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-03 00:55 ESTNewsEdesa Biotech receives C$14M for COVID-19 studyN/A
2021-01-26 23:12 ESTNewsEdesa nabs regulatory nod for sub set of phase2/3 EB05 COVID-19 studyN/A
2021-01-20 17:24 ESTNewsNFLX, TELL, CLBS, and FUTU among notable pre-market gainersN/A
2021-01-20 17:23 ESTNewsEdesa slated for a panel discussion at a government COVID-19 eventN/A
2020-12-11 11:33 ESTEarnings EstimateAn EPS average of -$0.17 is estimated for the quarter ending on March 31, 2021.Buy
2020-12-11 11:33 ESTEarnings EstimateAn EPS average of -$0.16 is estimated for the quarter ending on December 31, 2020.Buy
2020-12-11 11:33 ESTAnalyst RatingThe Analyst Target Price has decreased from $16 to $15.5.Neutral
2020-12-09 19:46 ESTFinancialsCompany financials have been released.Neutral
2020-12-08 11:41 ESTEarnings EstimateAn EPS average of -$1.89 is estimated for the 2022 year.Sell
2020-12-08 02:51 ESTNewsEdesa Biotech EPS misses by $0.04, beats on revenueN/A
2020-11-26 19:49 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-04 01:03 ESTNewsEdesa Biotech's lead asset mid-stage dermatitis study achieves 50% enrollmentN/A
2020-10-19 20:06 ESTNewsEdesa on go with Phase 2/3 study of EB05 in COVID-19N/A
2020-09-26 12:37 ESTFinancialsCompany financials have been released.Neutral
2020-09-19 11:03 ESTNewsCEO Pardeep Nijhawan increases stake in Edesa BiotechN/A
2020-09-17 04:45 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 16:32 ESTFinancialsCompany financials have been released.Neutral

About Edesa Biotech, Inc (EDSA):

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 2/Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical cream containing non-steroidal anti-inflammatory compound that is in Phase 2B clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of sPLA2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, a monoclonal antibody candidate. It has a collaboration agreement with NovImmune SA to develop products containing toll-like receptor 4 and chemokine ligand 10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

EDSA Quotes by TradingView

See Advanced Chart

General

  • Name Edesa Biotech, Inc
  • Symbol EDSA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 12
  • Last Split Factor1:6
  • Last Split Date2019-06-10
  • Fiscal Year EndSeptember
  • IPO Date2015-11-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.edesabiotech.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 239.03
  • Price/Book (Most Recent Quarter) 9.49
  • Enterprise Value Revenue 310.87
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.07
  • Next Year EPS Estimate -$1.84
  • Next Quarter EPS Estimate -$0.27
  • Operating Margin -3579%
  • Return on Assets -64%
  • Return on Equity -117%
  • Revenue 221001
  • Earnings Per Share -$5.79
  • Revenue Per Share $0.02
  • Gross Profit 311200
  • Quarterly Earnings Growth -99.9%
View More

Highlights

  • Market Capitalization 74.85 million
  • EBITDA -2623543
  • Analyst Target Price $17
  • Book Value Per Share $0.56
View More

Share Statistics

  • Shares Outstanding 13.18 million
  • Shares Float 6.54 million
  • % Held by Insiders 3865%
  • % Held by Institutions 21.14%
  • Shares Short 268810
  • Shares Short Prior Month 89004
  • Short Ratio 0.2
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $10.15
  • 52 Week Low $1.7
  • 50 Day Moving Average 6.18
  • 200 Day Moving Average 6.18
View More

Dividends

  • Dividend Date 2019-06-10
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Edesa Biotech, Inc (EDSA) Dividend Calendar:

EDSA's last dividend payment was made to shareholders on June 10, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Edesa Biotech, Inc (EDSA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-16$N/A-$0.26-$0.22-18.18%
2020-09-302020-12-07$N/A-$0.22-$0.234.35%
2020-06-302020-08-12$N/A-$0.20-$0.2313.04%
2020-03-312020-05-15$110516-$0.17-$0.2634.62%
2019-12-312020-02-13$107800-$0.15
2019-03-312019-05-08$250-$1.86
2018-12-312019-02-05$N/A-$1.58
2018-09-302018-11-30$N/A-$1.27
2018-06-302018-08-08$N/A-$2.25
2018-03-312018-05-08$N/A-$5.40
2017-12-312018-02-05-$5.59
2017-09-302017-12-01-$4.87
2017-06-302017-08-09-$0.84-$0.77-9.09%
2017-03-312017-05-09-$0.77-$0.70-10%
2016-12-312017-02-06-$1.05-$0.70-50%
2016-09-302016-12-14-$0.91-$0.910%
2016-06-302016-08-09-$0.98-$0.84-16.67%
2016-03-312016-05-09-$0.70-$0.700%
2015-12-312016-02-08-$8.18
2015-09-302015-12-14-$0.19$0.05-480%
2015-06-302015-08-10$2.29
2015-03-312015-05-11-$2.25
2014-12-312015-02-09-$7.10
2014-09-302014-11-13-$2.80-$1.40-100%
2014-06-302014-07-10$9.75
2014-03-312014-04-30-$1.33
2013-12-312014-01-29-$31.96
2013-06-302013-08-31-$71.40
2013-03-312013-05-31-$9.20
2012-12-312013-02-28-$30.20
2012-09-302012-11-30-$6.84
2012-06-302012-08-31-$23.56
2012-03-312012-05-31-$10.76
2011-12-312012-02-29-$8.08
2011-09-302011-11-30-$6.61
2011-06-302011-08-31-$12.37
2011-03-312011-05-31-$13.13
2010-12-312011-02-28-$41.19
2010-09-302010-11-30-$11.79
2010-06-302010-08-31-$4.30

Edesa Biotech, Inc (EDSA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Edesa Biotech, Inc (EDSA) Chart:

Edesa Biotech, Inc (EDSA) News:

Below you will find a list of latest news for Edesa Biotech, Inc (EDSA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Edesa Biotech, Inc (EDSA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest EDSA Trades:

Date Shares Price
Jun 13, 2022 2:52 PM EST100$1.7
Jun 13, 2022 4:59 PM EST100$1.76
Jun 13, 2022 5:25 PM EST100$1.74
Jun 13, 2022 6:14 PM EST100$1.715
Jun 13, 2022 7:58 PM EST100$1.71

Edesa Biotech, Inc (EDSA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420006075/0001654954-20-006075-index.htm
2018-06-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1540159/000000000018018283/0000000000-18-018283-index.htm
2019-09-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1540159/000000000019013355/0000000000-19-013355-index.htm
2020-02-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1540159/000000000020001802/0000000000-20-001802-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000105387819000001/0001053878-19-000001-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000110465919042699/0001104659-19-042699-index.htm
2018-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418028928/0001144204-18-028928-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418029362/0001144204-18-029362-index.htm
2018-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418030411/0001144204-18-030411-index.htm
2018-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418031433/0001144204-18-031433-index.htm
2018-06-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1540159/000114420418032928/0001144204-18-032928-index.htm
2018-06-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1540159/000114420418034062/0001144204-18-034062-index.htm
2018-06-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1540159/000114420418034464/0001144204-18-034464-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418042551/0001144204-18-042551-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000114420418042847/0001144204-18-042847-index.htm
2018-08-08424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1540159/000114420418042853/0001144204-18-042853-index.htm
2018-10-02424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1540159/000114420418052074/0001144204-18-052074-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418052077/0001144204-18-052077-index.htm
2018-10-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420418053712/0001144204-18-053712-index.htm
2018-10-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420418053713/0001144204-18-053713-index.htm
2018-11-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420418062445/0001144204-18-062445-index.htm
2018-11-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1540159/000114420418062614/0001144204-18-062614-index.htm
2018-12-04POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1540159/000114420418063164/0001144204-18-063164-index.htm
2018-12-05POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1540159/000114420418063178/0001144204-18-063178-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420419005028/0001144204-19-005028-index.htm
2019-02-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000114420419005062/0001144204-19-005062-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420419012862/0001144204-19-012862-index.htm
2019-03-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1540159/000114420419012863/0001144204-19-012863-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013348/0001144204-19-013348-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013778/0001144204-19-013778-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013779/0001144204-19-013779-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013780/0001144204-19-013780-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013781/0001144204-19-013781-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013782/0001144204-19-013782-index.htm
2019-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419013783/0001144204-19-013783-index.htm
2019-03-29PREM14APreliminary proxy statements relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1540159/000114420419016994/0001144204-19-016994-index.htm
2019-04-18DEFM14ADefinitive proxy statement relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1540159/000114420419020301/0001144204-19-020301-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420419024376/0001144204-19-024376-index.htm
2019-05-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1540159/000114420419024377/0001144204-19-024377-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000114420419024522/0001144204-19-024522-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420419028915/0001144204-19-028915-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420419030359/0001144204-19-030359-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419030608/0001144204-19-030608-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000114420419030609/0001144204-19-030609-index.htm
2019-06-17SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000114420419031159/0001144204-19-031159-index.htm
2019-06-17SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000114420419031195/0001144204-19-031195-index.htm
2019-06-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000114420419031460/0001144204-19-031460-index.htm
2019-06-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000114420419031709/0001144204-19-031709-index.htm
2019-06-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000114420419032265/0001144204-19-032265-index.htm
2018-06-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1540159/000121390018007211/0001213900-18-007211-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1540159/000121390019001912/0001213900-19-001912-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1540159/000121390020003222/0001213900-20-003222-index.htm
2019-01-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1540159/000153561019000032/0001535610-19-000032-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495419009564/0001654954-19-009564-index.htm
2019-08-148-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495419009573/0001654954-19-009573-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000165495419009578/0001654954-19-009578-index.htm
2019-08-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495419009776/0001654954-19-009776-index.htm
2019-08-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495419009777/0001654954-19-009777-index.htm
2019-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495419010201/0001654954-19-010201-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1540159/000165495419010204/0001654954-19-010204-index.htm
2019-09-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495419010487/0001654954-19-010487-index.htm
2019-09-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495419010489/0001654954-19-010489-index.htm
2019-09-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1540159/000165495419010495/0001654954-19-010495-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495419010741/0001654954-19-010741-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495419012009/0001654954-19-012009-index.htm
2019-10-25DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1540159/000165495419012011/0001654954-19-012011-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495419013870/0001654954-19-013870-index.htm
2019-12-1210-KTTransition reports [Rule 13a-10 or 15d-10]https://www.sec.gov/Archives/edgar/data/1540159/000165495419013878/0001654954-19-013878-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000145/0001654954-20-000145-index.htm
2020-01-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1540159/000165495420000147/0001654954-20-000147-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000227/0001654954-20-000227-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000265/0001654954-20-000265-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000267/0001654954-20-000267-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000269/0001654954-20-000269-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000270/0001654954-20-000270-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000308/0001654954-20-000308-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000310/0001654954-20-000310-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000313/0001654954-20-000313-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000314/0001654954-20-000314-index.htm
2020-01-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000335/0001654954-20-000335-index.htm
2020-01-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000336/0001654954-20-000336-index.htm
2020-01-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000338/0001654954-20-000338-index.htm
2020-01-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000350/0001654954-20-000350-index.htm
2020-01-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000542/0001654954-20-000542-index.htm
2020-01-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000543/0001654954-20-000543-index.htm
2020-01-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000675/0001654954-20-000675-index.htm
2020-01-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420000847/0001654954-20-000847-index.htm
2020-02-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000165495420001496/0001654954-20-001496-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001506/0001654954-20-001506-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001647/0001654954-20-001647-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001649/0001654954-20-001649-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001650/0001654954-20-001650-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001651/0001654954-20-001651-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001652/0001654954-20-001652-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001653/0001654954-20-001653-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001654/0001654954-20-001654-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420001655/0001654954-20-001655-index.htm
2020-02-25S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1540159/000165495420001897/0001654954-20-001897-index.htm
2020-03-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1540159/000165495420002234/0001654954-20-002234-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420002851/0001654954-20-002851-index.htm
2020-03-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420002997/0001654954-20-002997-index.htm
2020-03-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1540159/000165495420003107/0001654954-20-003107-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420003384/0001654954-20-003384-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420004346/0001654954-20-004346-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420005407/0001654954-20-005407-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420005546/0001654954-20-005546-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000165495420005548/0001654954-20-005548-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420006029/0001654954-20-006029-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420006075/0001654954-20-006075-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420008899/0001654954-20-008899-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1540159/000165495420008905/0001654954-20-008905-index.htm
2020-09-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1540159/000165495420010216/0001654954-20-010216-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420010224/0001654954-20-010224-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420010533/0001654954-20-010533-index.htm
2020-09-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1540159/000165495420010535/0001654954-20-010535-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1540159/000165495420010537/0001654954-20-010537-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011139/0001654954-20-011139-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011140/0001654954-20-011140-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011141/0001654954-20-011141-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011142/0001654954-20-011142-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011144/0001654954-20-011144-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011149/0001654954-20-011149-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011150/0001654954-20-011150-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011151/0001654954-20-011151-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011152/0001654954-20-011152-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011786/0001654954-20-011786-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011793/0001654954-20-011793-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011925/0001654954-20-011925-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000165495420011927/0001654954-20-011927-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177796219000001/0001777962-19-000001-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/0001777962-19-000002-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/0001777962-19-000003-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177798819000001/0001777988-19-000001-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177848019000001/0001778480-19-000001-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177848019000002/0001778480-19-000002-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177848019000003/0001778480-19-000003-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177898119000001/0001778981-19-000001-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177898119000002/0001778981-19-000002-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177898119000003/0001778981-19-000003-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177912619000001/0001779126-19-000001-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177912619000002/0001779126-19-000002-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1540159/000177912619000003/0001779126-19-000003-index.htm
2018-06-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1540159/999999999518001522/9999999995-18-001522-index.htm
2018-12-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1540159/999999999518003075/9999999995-18-003075-index.htm
2018-12-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1540159/999999999518003076/9999999995-18-003076-index.htm
2019-09-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1540159/999999999519002082/9999999995-19-002082-index.htm
2020-03-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1540159/999999999520000480/9999999995-20-000480-index.htm

Edesa Biotech, Inc (EDSA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Edesa Biotech, Inc (EDSA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3865%
Institutional Ownership: 2114%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-01-08FRANK R. OAKESDirectorBuy1,218.004.115,005.981,218.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000313/0001654954-20-000313-index.htm
2020-01-08KATHI NIFFENEGGERChief Financial OfficerBuy1,218.004.115,005.981,218.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000310/0001654954-20-000310-index.htm
2019-06-07Sean Arthur MacDonaldDirectorBuy13,583.0013,583.00https://www.sec.gov/Archives/edgar/data/1540159/000177898119000002/0001778981-19-000002-index.htm
2019-07-26Sean Arthur MacDonaldDirectorBuy786.0014,369.00https://www.sec.gov/Archives/edgar/data/1540159/000177898119000003/0001778981-19-000003-index.htm
2019-06-07der Velden Peter vanDirectorBuy148,999.00148,999.00https://www.sec.gov/Archives/edgar/data/1540159/000114420419030609/0001144204-19-030609-index.htm
2019-07-26der Velden Peter vanDirectorBuy8,600.00157,599.00https://www.sec.gov/Archives/edgar/data/1540159/000110465919042699/0001104659-19-042699-index.htm
2019-06-07der Velden Peter vanDirectorBuy1,611,338.001,611,338.00https://www.sec.gov/Archives/edgar/data/1540159/000114420419030609/0001144204-19-030609-index.htm
2020-01-08der Velden Peter vanDirectorBuy11,903.003.2038,089.60169,502.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000270/0001654954-20-000270-index.htm
2019-07-26der Velden Peter vanDirectorBuy93,006.001,704,344.00https://www.sec.gov/Archives/edgar/data/1540159/000110465919042699/0001104659-19-042699-index.htm
2020-01-08Michael J BrooksPresidentBuy1,827.004.117,508.971,827.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000265/0001654954-20-000265-index.htm
2020-01-08der Velden Peter vanDirectorBuy128,722.003.20411,910.401,833,066.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000270/0001654954-20-000270-index.htm
2019-06-07Pardeep NijhawanChief Executive OfficerBuy1,988,424.001,988,424.00https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/0001777962-19-000002-index.htm
2018-10-12DANIEL E. MORSEInsiderSell7,047.001.319,259.7620,741.00https://www.sec.gov/Archives/edgar/data/1540159/000114420418053713/0001144204-18-053713-index.htm
2019-07-26Pardeep NijhawanChief Executive OfficerBuy118,345.002,106,769.00https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/0001777962-19-000003-index.htm
2019-06-07Pardeep NijhawanChief Executive OfficerBuy211,506.00211,506.00https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/0001777962-19-000002-index.htm
2020-01-08Pardeep NijhawanChief Executive OfficerBuy9,255.004.1138,038.052,116,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000314/0001654954-20-000314-index.htm
2020-03-17Pardeep NijhawanChief Executive OfficerBuy1,000.001.891,889.902,117,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420002851/0001654954-20-002851-index.htm
2020-03-17Pardeep NijhawanChief Executive OfficerBuy1,000.001.861,859.902,118,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420002851/0001654954-20-002851-index.htm
2020-03-17Pardeep NijhawanChief Executive OfficerBuy1,000.001.901,897.802,119,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420002851/0001654954-20-002851-index.htm
2020-03-17Pardeep NijhawanChief Executive OfficerBuy1,000.001.831,828.002,120,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420002851/0001654954-20-002851-index.htm
2020-03-17Pardeep NijhawanChief Executive OfficerBuy1,000.001.901,897.502,121,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420002851/0001654954-20-002851-index.htm
2020-05-26Pardeep NijhawanChief Executive OfficerBuy3,000.002.988,939.102,124,024.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420006029/0001654954-20-006029-index.htm
2019-07-26Pardeep NijhawanChief Executive OfficerBuy12,588.00224,094.00https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/0001777962-19-000003-index.htm
2020-01-08Carlo SistilliDirectorBuy2,436.004.1110,011.962,436.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000269/0001654954-20-000269-index.htm
2020-01-08Paul William PayDirectorBuy2,436.004.1110,011.962,436.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000308/0001654954-20-000308-index.htm
2020-05-27Michael J BrooksPresidentBuy1,500.003.004,498.503,327.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420006075/0001654954-20-006075-index.htm
2020-05-27Michael J BrooksPresidentBuy1,000.003.003,000.004,327.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420006075/0001654954-20-006075-index.htm
2019-03-06FRANK R. OAKESPresident & CEOSell4,000.001.255,000.4047,924.00https://www.sec.gov/Archives/edgar/data/1540159/000114420419013348/0001144204-19-013348-index.htm
2019-06-07Pardeep NijhawanChief Executive OfficerBuy507,129.00507,129.00https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/0001777962-19-000002-index.htm
2018-10-12FRANK R. OAKESPresident & CEOSell3,000.001.313,930.0051,924.00https://www.sec.gov/Archives/edgar/data/1540159/000114420418053712/0001144204-18-053712-index.htm
2019-07-26Pardeep NijhawanChief Executive OfficerBuy30,183.00537,312.00https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/0001777962-19-000003-index.htm
2019-09-11FRANK R. OAKESDirectorSell1,809.005.7210,345.136,165.00https://www.sec.gov/Archives/edgar/data/1540159/000165495419010741/0001654954-19-010741-index.htm
2020-01-08LORIN K JOHNSONDirectorBuy8,524.004.1135,033.648,524.00https://www.sec.gov/Archives/edgar/data/1540159/000165495420000267/0001654954-20-000267-index.htm